UK trial tests shortening breast cancer radiotherapy to five days

More than 1,000 people have joined a government-funded trial to see if radiotherapy can be cut from three weeks to five days.

A government-funded clinical trial is testing whether breast cancer radiotherapy can be shortened from three weeks to five days. The FAST-Forward Boost trial is being conducted at 39 hospitals across the United Kingdom. The study assesses whether a shorter course of radiotherapy combined with an additional targeted dose, known as a boost, can help prevent breast cancer from returning.

More than 1,000 people have joined the trial, which is led by the Institute of Cancer Research, London, and funded through the National Institute for Health and Care Research. The department aims to recruit 4,830 participants by 2028, with those enrolled to be followed up for five years. Results are expected in 2033.

Health and Social Care Secretary Yvette Cooper said the trial demonstrates how the UK is using its research capabilities to improve cancer treatment. If successful, the shorter treatment schedule could reduce patients' travel costs and time away from work and family while freeing up capacity in the National Health Service to treat more people.

The announcement comes as the government steps up efforts to improve breast cancer screening, early diagnosis, and support for patients. Breast screening uptake among women receiving their first invitation has reached 63.6 per cent, the highest level in a decade, though around four in 10 women invited for the first time do not attend.

In a related development, West Lancashire MP Ashley Dalton has been appointed as the Government's adviser for the National Cancer Plan. Ms Dalton, who is living with metastatic breast cancer, will advise ministers on improving cancer care and helping to deliver commitments set out in the plan. She will also assess whether the plan is improving quality of life and patient experience for people affected by cancer.

Key facts

  • The FAST-Forward Boost trial is testing if breast cancer radiotherapy can be cut from three weeks to five days.
  • The trial aims to recruit 4,830 participants by 2028.
  • Results from the trial are expected in 2033.

Three perspectives

Neutral

The FAST-Forward Boost trial is testing a shorter course of radiotherapy at 39 UK hospitals.

Positive

If successful, the shorter treatment could reduce travel costs and time away from work for patients.

Negative

Around four in 10 women invited for their first breast cancer screening do not attend.

Your week in news, every Wednesday

The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.

Choose your news coverage

Please choose and confirm your coverage.

Study identifies racial differences in pancreatic cancer tumor cells
Next storyStudy identifies racial differences in pancreatic cancer tumor cells

All sections

Edition